Morgan Stanley’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-805
| Closed | -$26K | – | 6864 |
|
|
2019
Q4 | $26K | Hold |
805
| – | – | ﹤0.01% | 6047 |
|
|
2019
Q3 | $15K | Hold |
805
| – | – | ﹤0.01% | 6103 |
|
|
2019
Q2 | $21K | Hold |
805
| – | – | ﹤0.01% | 5929 |
|
|
2019
Q1 | $24K | Hold |
805
| – | – | ﹤0.01% | 5959 |
|
|
2018
Q4 | $16K | Hold |
805
| – | – | ﹤0.01% | 6069 |
|
|
2018
Q3 | $36K | Sell |
805
-100
| -11% | -$4.47K | ﹤0.01% | 5978 |
|
|
2018
Q2 | $30K | Sell |
905
-1
| -0.1% | -$33 | ﹤0.01% | 6047 |
|
|
2018
Q1 | $29K | Buy |
906
+606
| +202% | +$19.4K | ﹤0.01% | 6044 |
|
|
2017
Q4 | $10K | Sell |
300
-600
| -67% | -$20K | ﹤0.01% | 6224 |
|
|
2017
Q3 | $35K | Sell |
900
-2
| -0.2% | -$78 | ﹤0.01% | 5885 |
|
|
2017
Q2 | $29K | Sell |
902
-100
| -10% | -$3.22K | ﹤0.01% | 6008 |
|
|
2017
Q1 | $28K | Sell |
1,002
-400
| -29% | -$11.2K | ﹤0.01% | 5988 |
|
|
2016
Q4 | $30K | Buy |
1,402
+1,010
| +258% | +$21.6K | ﹤0.01% | 5893 |
|
|
2016
Q3 | $11K | Sell |
392
-200
| -34% | -$5.61K | ﹤0.01% | 6099 |
|
|
2016
Q2 | $13K | Buy |
+592
| New | +$13K | ﹤0.01% | 5996 |
|
|
2015
Q3 | – | Sell |
-17
| Closed | -$2K | – | 6806 |
|
|
2015
Q2 | $2K | Buy |
+17
| New | +$2K | ﹤0.01% | 6528 |
|